Trial intelligence / Profile preview

Vitamin D supplementation and immune activation in HIV-infected individuals on ART

2010-022775-57Phase 4Completed

Sponsor
Guy's and St Thomas' NHS Foundation Trust
Start
May 2011
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, single-arm trial of cholecalciferol in Vitamin D deficiency (VDD) and human immunodeficiency virus infection (HIV), sponsored by Guy's and St Thomas' NHS Foundation Trust. Primary endpoint: 25-hydroxyvitamin D level at week 48. Started May 2011; status: completed.

02

Drugs

cholecalciferol
03

Conditions

Vitamin D deficiency (VDD)human immunodeficiency virus infection (HIV)

Beyond the preview

Go deeper on 2010-022775-57.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2010-022775-57.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call